News

Organ transplants might never be the same again. Scientists have successfully 3D printed a human heart, marking a huge leap ...
Cervavac was developed by Serum Institute Of India (SII) in collaboration with central government’s department of ...
A team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific ...
GenomeIndia project publishes preliminary findings from sequencing 10,000 Indian genomes, highlighting unique genetic ...
But Youle’s dismissal, along with 10 others at the NIH’s National Institute of Neurological Disorders and Stroke, underscores ...
Biotechnology will have a transformative impact on defense, supply chains, agriculture, health and computing, all areas that ...
A Wuhan-based biopharmaceutical company developed technology to synthesize human serum albumin (HSA) from rice, offering a ...
Sponsored content brought to you by In the rapidly advancing field of immuno-oncology research, there has been increasing ...
Learn more about whether CRISPR Therapeutics AG or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
In a new book titled “Integral Transhumanism,” Spanish priest Ricardo Mejía Fernández examines the transhumanist movement.
Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...